CERK Antikörper

Produktnummer ABIN265120

Produktdetails anti-CERK Antikörper

Target: CERK (Ceramide Kinase (CERK))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CERK Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Spezifität: This antibody reacts to Ceramide Kinase.

Aufreinigung: Purified

Immunogen: Synthetic peptide derived from human ceramide kinase protein

Anwendungsinformationen

Applikationshinweise: ELISA. Western Blot: 1 - 10 μg/mL. Positive Control: High level expression in heart, brain, skeletal muscle, kidney and liver.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: Phosphate buffered saline with 0.08 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: The antibody can be shipped at ambient temperature. Store (in aliquots) at -20 °C only.

Details zu CERK

Target: CERK (Ceramide Kinase (CERK))

Andere Bezeichnung: Ceramide Kinase (CERK Produkte)

Synonyme: AI848610 antikoerper, D330016D08Rik antikoerper, mKIAA1646 antikoerper, LK4 antikoerper, dA59H18.2 antikoerper, dA59H18.3 antikoerper, hCERK antikoerper, CERK antikoerper, si:ch211-162i19.1 antikoerper, MGC81777 antikoerper, CG16708 antikoerper, DCERK antikoerper, Dcerk antikoerper, Dmel\\CG16708 antikoerper, dcerk antikoerper, ceramide kinase antikoerper, ceramide kinase S homeolog antikoerper, Ceramide kinase antikoerper, Cerk antikoerper, CERK antikoerper, cerk antikoerper, cerk.S antikoerper, CpipJ_CPIJ003342 antikoerper, LOAG_11245 antikoerper, LOC5579301 antikoerper, Bm1_50005 antikoerper

Hintergrund: Sphingolipids, in addition to being structural components of membranes, regulate cell-cell and cell-substrate interactions, proliferation, and differentiation. Members of this diverse group of lipids have emerged as a novel class of signaling molecules that also regulate phagocytosis. The mechanisms by which sphingolipids exert these effects remain incompletely defined. More than a decade ago, it was found that ceramide can be phosphorylated to ceramide 1-phosphate (C1P). Ceramide kinase (CERK) and its phosphorylated product ceramide 1-phosphate (C1P) are central players in inflammation and cancer. The product of CERK activity, ceramide 1-phosphate (C1P), has been reported to have mitogenic effects. C1P is a direct activator of cytosolic phospholipase A2 and is involved in arachidonic acid release. CERK is a mediator of Ca2+-dependent degranulation in mast cells. In both arachidonic acid release and mast cell degranulation, the intracellular elevation of Ca2+ is a central event that acts as a regulatory mechanism of CERK activity. C1P is found in brain synaptic vesicles, and plays a role in regulating the secretion of neurotransmitters. CERK activity exists in HL-60 cells where the C1P is derived from ceramide released from sphingomyelin. The expressed kinase has specific ceramide phosphorylating activity. CERKs exist in a variety of cellular organisms, including plants, nematodes, insects, and vertebrates.Synonyms: Acylsphingosine kinase, KIAA1646, LK4, Lipid kinase 4, hCERK

Gen-ID: 64781

NCBI Accession: NP_073603

UniProt: Q8TCT0